Sign in
8-K

Current Report

Spero Therapeutics, Inc. Filed Acc 0001193125-22-169252

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading d271182d8k.htm…